Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Richter, Stephan
NCT-PMO-1603, NCT03127215 / 2017-001755-31: Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors	Completed	2	102	Europe	Olaparib, Physician's choice, Trabectedin	National Center for Tumor Diseases, Heidelberg, AstraZeneca, PharmaMar, German Cancer Research Center	Cancers With DNA Repair-Deficiency	12/23	12/23